clinical trial · NCT06426485
To Evaluate the Long-term Efficacy and Safety of Toludevenlafaxine Hydrochloride Sustained-release Tablets
Major Depressive DisorderToludesvenlafaxine Hydrochloride Sustained-release Tabletsplacebo
brief summary
This is a multicenter, randomized withdrawal, double-blind, parallel, placebo-controlled design clinical trial of Toludesvenlafaxine Hydrochloride Extended-Release Tablets to evaluate the long-term efficacy and safety in the treatment of Chinese patients with depression.
started
May 30, 2024
primary completion
Feb 28, 2027
completion
Jun 30, 2027
last updated
May 23, 2024
official title
A Multicenter, Randomized Withdrawal, Double-blind, Parallel, Placebo-controlled Design Clinical Trial of Toludesvenlafaxine Hydrochloride Extended-Release Tablets
sourced from ClinicalTrials.gov · pharmadog mirrors structured fields, not the full protocol